Long-Acting Analog Insulin Doesn't Up AMI Risk in T2DM

This article originally appeared here.
Share this content:
Long-Acting Analog Insulin Doesn't Up AMI Risk in T2DM
Long-Acting Analog Insulin Doesn't Up AMI Risk in T2DM

THURSDAY, Aug. 20, 2015 (HealthDay News) -- For patients with type 2 diabetes, the risk of acute myocardial infarction (AMI) is not significantly different for long-acting insulin analogs versus other basal insulin therapies, according to a study published online Aug. 17 in Diabetes, Obesity and Metabolism.

Bianca Kollhorst, from the Leibniz Institute for Prevention Research and Epidemiology in Bremen, Germany, and colleagues examined the risk of AMI in patients with type 2 diabetes mellitus in a retrospective cohort study. The risk of AMI was compared for patients treated with long-acting insulin analogs versus other basal insulin therapy.

The researchers identified 21,501 new insulin users. Patients treated with premixed insulin were older than those treated with analog or human neutral protamine Hagedorn (NPH) insulin (mean age, 70.7 versus 64.1 and 61.6 years, respectively); they also had a higher number of comorbidities. There was no significant difference in the risk of AMI for those receiving NPH or analog insulin (hazard ratio, 0.94; 95 percent confidence interval, 0.74 to 1.19), but the risk was higher for premixed versus analog insulin (hazard ratio, 1.27; 95 percent confidence interval, 1.02 to 1.58). There was no increased risk for premixed insulin in propensity score-matched analysis.

"In contrast to a former database study, no difference was observed for the risk of AMI between long-acting analog and NPH insulin in this study," the authors write. "Neither long-acting analog insulin nor premix insulin appears to be associated with AMI in patients with type 2 diabetes."

Two authors are employed by Sanofi-Aventis, which funded the study.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease


More in Home

CDC: Too Many Health Care Workers Not Getting Flu Vaccine

CDC: Too Many Health Care Workers Not Getting ...

Vaccination protects both workers and patients

Early Mobilization Improves Outcomes, LOS in Surgical ICUs

Early Mobilization Improves Outcomes, LOS in Surgical ICUs

Patients discharged sooner, become more functional when they leave the hospital

is free, fast, and customized just for you!

Already a member?

Sign In Now »